Miriam J. Lohr - Publications

Apilimod in oncology: From non-malignant origins to emerging anti-cancer potential.

Journal: European journal of pharmacology

Published: November 01, 2025

Prognostic impact of inter-metastatic heterogeneity of viable tumour cells in colorectal liver metastases.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: February 10, 2022

Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: September 21, 2021

Identification of BBX proteins as rate-limiting cofactors of HY5.

Journal: Nature plants

Published: October 01, 2019

Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives.

Journal: International journal of epidemiology

Published: January 02, 2018

A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 08, 2017

Identification of sample annotation errors in gene expression datasets.

Journal: Archives of toxicology

Published: September 14, 2015

Loss of circadian clock gene expression is associated with tumor progression in breast cancer.

Journal: Cell cycle (Georgetown, Tex.)

Published: December 09, 2014

International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: November 05, 2014

An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 22, 2014

S3-guideline exocrine pancreatic cancer

Journal: Zeitschrift fur Gastroenterologie

Published: December 17, 2013

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.

Journal: International journal of cancer

Published: October 11, 2013